JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M501540200 on April 19, 2005

J. Biol. Chem., Vol. 280, Issue 25, 23559-23565, June 24, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/25/23559    most recent
M501540200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, H.
Right arrow Articles by Kamatchi, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, H.
Right arrow Articles by Kamatchi, G. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role of {alpha}1 2.3 Subunit I-II Linker Sites in the Enhancement of Cav 2.3 Current by Phorbol 12-Myristate 13-Acetate and Acetyl-{beta}-methylcholine*

Hongyu Fang, Ruthie Franke, Saharat Patanavanich, Amrita Lalvani, Natalie K. Powell, Julianne J. Sando, and Ganesan L. Kamatchi{ddagger}

From the Department of Anesthesiology, University of Virginia Health Sciences Systems, Charlottesville, Virginia 22908

Potentiation of Cav 2.3 currents by phorbol 12-myristate 13-acetate (PMA) or acetyl-{beta}-methylcholine (MCh) may be due to protein kinase C (PKC)-mediated phosphorylation of the {alpha}1 2.3 subunit. Mutational analysis of potential PKC sites unique to the {alpha}1 2.3 subunit revealed several sites in the II-III linker that are specific to MCh (Kamatchi, G., Franke, R., Lynch, C., III, and Sando, J. (2004) J. Biol. Chem. 279, 4102–4109). To identify sites responsive to PMA, Ser/Thr -> Ala mutations were made in potential PKC sites homologous to the {alpha}1 2.3 and 2.2 subunits, both of which respond to PMA. Wild type {alpha}1 2.3 or mutants were expressed in Xenopus oocytes in combination with {beta}1b and {alpha}2/{delta} subunits and muscarinic M1 receptors. Inward current (IBa) was recorded using Ba2+ as the charge carrier. Thr-365 of the I-II linker was identified as the primary site of PMA action, and this site also was required, along with the previously identified MCh-selective sites, for the MCh response. Ser-369 and Ser-1995 contributed to current enhancement only if Thr-365 also was available. Mutation of the essential sites to Asp increased the basal IBa and caused a corresponding decrease in the PMA or MCh responses, consistent with possible regulation of these sites by phosphorylation. These results suggest that PMA and MCh both activate a pathway that can regulate the common PMA-sensitive sites in the I-II linker but that MCh also activates an additional pathway required for regulation of the MCh-unique sites, especially in the II-III linker.


Received for publication, February 9, 2005 , and in revised form, April 14, 2005.

* This work was supported by National Institutes of Health Grant GM65214 (to G. L. K.) and GM31184 (to J. J. S.) and by the Department of Anesthesiology at the University of Virginia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Anesthesiology, University of Virginia Health Sciences System, P. O. Box 800710, Charlottesville, VA 22908-0710. Tel.: 434-924-2924; Fax: 434-982-0019; E-mail: gk3p{at}virginia.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
C. Toro-Castillo, A. Thapliyal, H. Gonzalez-Ochoa, B. A. Adams, and U. Meza
Muscarinic modulation of Cav2.3 (R-type) calcium channels is antagonized by RGS3 and RGS3T
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C573 - C580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Fang, S. Patanavanich, S. Rajagopal, X. Yi, M. S. Gill, J. J. Sando, and G. L. Kamatchi
Inhibitory Role of Ser-425 of the {alpha}1 2.2 Subunit in the Enhancement of Cav 2.2 Currents by Phorbol-12-myristate, 13-Acetate
J. Biol. Chem., July 21, 2006; 281(29): 20011 - 20017.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.